超高危精神病患者和未服药的首发精神病患者的嗅觉识别能力受损

IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY
Lijun Ouyang , Xiaoqian Ma , Liu Yuan , Lejia Fan , Aijun Liao , David Li , Zihao Yang , Zhenmei Zhang , Weiqing Liu , Xiaogang Chen , Zongchang Li , Ying He
{"title":"超高危精神病患者和未服药的首发精神病患者的嗅觉识别能力受损","authors":"Lijun Ouyang ,&nbsp;Xiaoqian Ma ,&nbsp;Liu Yuan ,&nbsp;Lejia Fan ,&nbsp;Aijun Liao ,&nbsp;David Li ,&nbsp;Zihao Yang ,&nbsp;Zhenmei Zhang ,&nbsp;Weiqing Liu ,&nbsp;Xiaogang Chen ,&nbsp;Zongchang Li ,&nbsp;Ying He","doi":"10.1016/j.pnpbp.2024.111035","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Patients with psychotic diseases have been reported to exhibit abnormalities in their olfactory discrimination. These alterations have also been identified in people at high genetic or clinical risk for psychosis, suggesting olfactory discrimination dysfunction may be a potential risk factor for developing psychosis. Thus, the purpose of our study is to explore the difference in olfactory discrimination ability in the prosal stage and early stage of psychosis and to explore the potential risk factor of developed psychosis.</p></div><div><h3>Methods</h3><p>We compared olfactory identification and cognitive function in 89 ultra-high-risk (UHR) individuals, 103 individuals with Drug-naïve first-episode schizophrenia (FES), 81 genetic high-risk (GHR) individuals, and 97 healthy controls (HC). Additionally, we compared olfactory identification and cognitive function between two groups; UHR individuals who later transitioned to psychosis (UHR-T; <em>n</em> = 33) and those who did not transition (UHR-NT; <em>n</em> = 42)). Furthermore, we analyzed the correlations between olfactory discrimination ability and cognitive function and symptoms and compared the olfactory function between men and women.</p></div><div><h3>Results</h3><p>Patients with first-episode schizophrenia (FES) and those at ultra-high risk (UHR) for psychosis exhibited more significant deficits in olfactory identification than healthy controls (HC), while no differences in olfactory identification dysfunction were observed between the genetic high risk (GHR) and HC groups. Notably, individuals in the UHR group who later developed psyhchosis displayed a steeper marked decline in their baseline olfactory identification ability than that of those in the UHR group who did not develop psychosis. Cognitive dysfunction is widely observed in both the FES and UHR groups, with a distinct correlation identified between olfactory discrimination function and cognitive performance. Finally, overall, women exhibit significantly superior olfactory function than men.</p></div><div><h3>Conclusion</h3><p>In conclusion, these findings suggest that impairment of olfactory identification exists in the early stage of psychosis. Olfactory identification dysfunction may therefore be a potential marker of predicting the transition to schizophrenia.</p></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":null,"pages":null},"PeriodicalIF":5.3000,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impairment of olfactory identification ability in ultra-high risk for psychosis and drug-naïve first episode psychosis\",\"authors\":\"Lijun Ouyang ,&nbsp;Xiaoqian Ma ,&nbsp;Liu Yuan ,&nbsp;Lejia Fan ,&nbsp;Aijun Liao ,&nbsp;David Li ,&nbsp;Zihao Yang ,&nbsp;Zhenmei Zhang ,&nbsp;Weiqing Liu ,&nbsp;Xiaogang Chen ,&nbsp;Zongchang Li ,&nbsp;Ying He\",\"doi\":\"10.1016/j.pnpbp.2024.111035\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>Patients with psychotic diseases have been reported to exhibit abnormalities in their olfactory discrimination. These alterations have also been identified in people at high genetic or clinical risk for psychosis, suggesting olfactory discrimination dysfunction may be a potential risk factor for developing psychosis. Thus, the purpose of our study is to explore the difference in olfactory discrimination ability in the prosal stage and early stage of psychosis and to explore the potential risk factor of developed psychosis.</p></div><div><h3>Methods</h3><p>We compared olfactory identification and cognitive function in 89 ultra-high-risk (UHR) individuals, 103 individuals with Drug-naïve first-episode schizophrenia (FES), 81 genetic high-risk (GHR) individuals, and 97 healthy controls (HC). Additionally, we compared olfactory identification and cognitive function between two groups; UHR individuals who later transitioned to psychosis (UHR-T; <em>n</em> = 33) and those who did not transition (UHR-NT; <em>n</em> = 42)). Furthermore, we analyzed the correlations between olfactory discrimination ability and cognitive function and symptoms and compared the olfactory function between men and women.</p></div><div><h3>Results</h3><p>Patients with first-episode schizophrenia (FES) and those at ultra-high risk (UHR) for psychosis exhibited more significant deficits in olfactory identification than healthy controls (HC), while no differences in olfactory identification dysfunction were observed between the genetic high risk (GHR) and HC groups. Notably, individuals in the UHR group who later developed psyhchosis displayed a steeper marked decline in their baseline olfactory identification ability than that of those in the UHR group who did not develop psychosis. Cognitive dysfunction is widely observed in both the FES and UHR groups, with a distinct correlation identified between olfactory discrimination function and cognitive performance. Finally, overall, women exhibit significantly superior olfactory function than men.</p></div><div><h3>Conclusion</h3><p>In conclusion, these findings suggest that impairment of olfactory identification exists in the early stage of psychosis. Olfactory identification dysfunction may therefore be a potential marker of predicting the transition to schizophrenia.</p></div>\",\"PeriodicalId\":54549,\"journal\":{\"name\":\"Progress in Neuro-Psychopharmacology & Biological Psychiatry\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2024-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Progress in Neuro-Psychopharmacology & Biological Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0278584624001039\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0278584624001039","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的据报道,精神病患者的嗅觉辨别能力出现异常。在精神病遗传或临床高危人群中也发现了这些改变,这表明嗅觉辨别功能障碍可能是罹患精神病的潜在风险因素。因此,我们的研究旨在探讨前驱期和早期精神病患者嗅觉辨别能力的差异,并探讨精神病发病的潜在风险因素。方法我们比较了89名超高危(UHR)患者、103名药物治疗无效的首发精神分裂症(FES)患者、81名遗传高危(GHR)患者和97名健康对照(HC)患者的嗅觉辨别能力和认知功能。此外,我们还比较了两组人的嗅觉识别能力和认知功能;即后来转为精神病的 UHR 人(UHR-T;n = 33)和未转为精神病的 UHR 人(UHR-NT;n = 42))。此外,我们还分析了嗅觉辨别能力与认知功能和症状之间的相关性,并对男性和女性的嗅觉功能进行了比较。结果与健康对照组(HC)相比,首发精神分裂症(FES)患者和精神病超高风险(UHR)患者在嗅觉辨别方面表现出更明显的缺陷,而遗传高风险(GHR)组和健康对照组在嗅觉辨别功能障碍方面没有发现差异。值得注意的是,与未患精神病的 UHR 组患者相比,后来患上精神病的 UHR 组患者的基线嗅觉识别能力明显下降得更快。认知功能障碍在 FES 组和 UHR 组中都普遍存在,嗅觉辨别功能与认知表现之间存在明显的相关性。最后,总体而言,女性的嗅觉功能明显优于男性。因此,嗅觉识别功能障碍可能是预测向精神分裂症转变的潜在标志。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impairment of olfactory identification ability in ultra-high risk for psychosis and drug-naïve first episode psychosis

Objective

Patients with psychotic diseases have been reported to exhibit abnormalities in their olfactory discrimination. These alterations have also been identified in people at high genetic or clinical risk for psychosis, suggesting olfactory discrimination dysfunction may be a potential risk factor for developing psychosis. Thus, the purpose of our study is to explore the difference in olfactory discrimination ability in the prosal stage and early stage of psychosis and to explore the potential risk factor of developed psychosis.

Methods

We compared olfactory identification and cognitive function in 89 ultra-high-risk (UHR) individuals, 103 individuals with Drug-naïve first-episode schizophrenia (FES), 81 genetic high-risk (GHR) individuals, and 97 healthy controls (HC). Additionally, we compared olfactory identification and cognitive function between two groups; UHR individuals who later transitioned to psychosis (UHR-T; n = 33) and those who did not transition (UHR-NT; n = 42)). Furthermore, we analyzed the correlations between olfactory discrimination ability and cognitive function and symptoms and compared the olfactory function between men and women.

Results

Patients with first-episode schizophrenia (FES) and those at ultra-high risk (UHR) for psychosis exhibited more significant deficits in olfactory identification than healthy controls (HC), while no differences in olfactory identification dysfunction were observed between the genetic high risk (GHR) and HC groups. Notably, individuals in the UHR group who later developed psyhchosis displayed a steeper marked decline in their baseline olfactory identification ability than that of those in the UHR group who did not develop psychosis. Cognitive dysfunction is widely observed in both the FES and UHR groups, with a distinct correlation identified between olfactory discrimination function and cognitive performance. Finally, overall, women exhibit significantly superior olfactory function than men.

Conclusion

In conclusion, these findings suggest that impairment of olfactory identification exists in the early stage of psychosis. Olfactory identification dysfunction may therefore be a potential marker of predicting the transition to schizophrenia.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
12.00
自引率
1.80%
发文量
153
审稿时长
56 days
期刊介绍: Progress in Neuro-Psychopharmacology & Biological Psychiatry is an international and multidisciplinary journal which aims to ensure the rapid publication of authoritative reviews and research papers dealing with experimental and clinical aspects of neuro-psychopharmacology and biological psychiatry. Issues of the journal are regularly devoted wholly in or in part to a topical subject. Progress in Neuro-Psychopharmacology & Biological Psychiatry does not publish work on the actions of biological extracts unless the pharmacological active molecular substrate and/or specific receptor binding properties of the extract compounds are elucidated.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信